Skip to main content
Signal8
Launch Terminal

GELSTAT CORP (GSAC)

GelStat Corporation operates as a consumer healthcare enterprise, specializing in the innovation, formulation, and commercialization of over-the-counter (OTC) and other non-prescription health solutions. Its diverse product portfolio addresses various common health concerns, featuring: GelStat Migraine, a patented remedy targeting migraine headache pain; Chews 2 Lose, an appetite-controlling gum designed to assist with weight management; All Natural Speed, formulated as an energy booster; and GelStat Sleep, intended to alleviate sleep disturbances and their related symptoms. GelStat distributes its solutions through a comprehensive network, reaching retailers, wholesalers, specialized distributors, and catalog merchandisers. This is achieved both through direct sales and via independent sales brokerage agreements. The corporation maintains its principal office in Palm City, Florida.

Sector: Pharmaceutical Preparations

Industry: Medical - Pharmaceuticals

GelStat Corporation logo

GelStat Corporation

OTC:GSACHealthcare
$0.0003
Mkt Cap$185K
Float530.21M
O/S617.98M
Inst Own-
SI<0.1%
Dilution
GelStat Corporation logoOTC:GSAC$0.0003
Historical Data
DateOpenHighLowCloseVolume
Key Metrics
Market Cap$185,394
Enterprise Value--
P/E Ratio--
Est. Net Cash/Share--
Institutional Ownership--

based on 617.98M shares outstanding

SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ExchangeOTC
CountryUSUS
IPO DateFeb 9, 1996
Shares Outstanding617.98M
Float530.21M
Company Overview

GelStat Corporation operates as a consumer healthcare enterprise, specializing in the innovation, formulation, and commercialization of over-the-counter (OTC) and other non-prescription health solutions.

Its diverse product portfolio addresses various common health concerns, featuring: GelStat Migraine, a patented remedy targeting migraine headache pain; Chews 2 Lose, an appetite-controlling gum designed to assist with weight management; All Natural Speed, formulated as an energy booster; and GelStat Sleep, intended to alleviate sleep disturbances and their related symptoms. GelStat distributes its solutions through a comprehensive network, reaching retailers, wholesalers, specialized distributors, and catalog merchandisers. This is achieved both through direct sales and via independent sales brokerage agreements. The corporation maintains its principal office in Palm City, Florida.

Leadership

Charles F. Tarzian

Chief Marketing Advisor

Javier G. Acosta

Chief Executive Officer & Director

Roger K. Cady

Chief Medical Advisor

Employees

2

Country

US

Sector

Healthcare

Website

gelstat.com

Analyst Coverage
No analyst coverage for this companyNo ratings, price targets, or covering firms on file.
Insider Trades
No insider transactions for this companyForeign private issuers and non-reporting entities don't file Form 4/5.
Shareholders
--
Institutional
(0)
--
Insiderⓘ
(0)
--
5%+ Owners
(0)
--
Unattributed (incl. retail)ⓘ
Sources:
52-Week Range
$0.0002$0.0004
$0.0003(50th percentile)
Volume
Average Daily Volume6.12M
26.00K today vs 6.12M avg(-100%)

30d Avg

6.12M

60d Avg

4.27M

90d Avg

3.33M

Earnings
Dividend History
No dividend history available
Compliance Status
Loading compliance data...